TrialBeacon
USClinicalTrials.govClinical trialRecruiting

A Study of Lung Cancer Risk

Open the official recordBack

Official record

Identifier
NCT07701733
Recruiting locations

country

United States
Interventions studied
Questionnaire
Lead sponsor
Memorial Sloan Kettering Cancer Center
Target enrolment
500 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Recruiting
First posted
Jul 14, 2026
Last updated on the registry
Aug 14, 2026
Age
40 Years – 74 Years
Sex
ALL
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Criteria:

* Female at birth
* Age 40-74 years
* No smoking history

  * Participants must be never-smokers, defined as having smoked \<100 cigarettes in their lifetime
* Documentation of disease - case patients

  o Case patients must have pathologically confirmed primary lung adenocarcinoma. New and prevalent cases will be eligible. Case patients with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.
* Criteria for control participants

  * Control participants must have no personal history of lung cancer, symptoms suspicious for lung cancer, or suspicious pulmonary nodules. Participants recruited as controls and found on imaging to have lesions suspicious for lung cancer will be excluded from analysis and followed prospectively. Data regarding these participants will be reported in a sensitivity analysis. Additional control participants will be recruited to ensure balanced age- and race-matched enrollment by frequency matching. Control participants with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.
Indexed under
Lung Cancer